Blackbaud Reports Q3 2025 Earnings with Revenue Growth and Product Pipeline Highlights
Blackbaud (BLKB) reported 6% constant currency revenue growth in Q3 2025, driven by its base business and innovative products, including $84 million in Miebo revenue and 27% growth in premium IOLs. The company highlighted its clinical-stage pipeline and upcoming Investor Day event.
Tickers: $BLKB
Topics: Blackbaud earnings enVista Miebo pipeline products Q3 2025 revenue growth